Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Explore well-known S&P 500 index funds for retirement 2024, focusing on performance, costs, and suitability for your plan.
22,695 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
A small, less-known U.S. LNG exporter is emerging as a potential winner as Europe faces a gas crunch amid Middle East...
Two U.S. startups, Archer Aviation and Joby Aviation, are racing to pioneer urban air mobility. This guide breaks dow...
Pi Network confirms the network’s next update complete as v19.9 wraps up and v20.2 moves into focus. The team aims to...
Uber is moving away from the idea of a laid-back culture. CEO Dara Khosrowshahi asserts a relentless work ethic, even...
EOS Energy Enterprises sparked a notable move in today’s trading. This article breaks down the possible catalysts beh...
Carl Icahn steps back from the activist spotlight as Michael Dell solidifies a long-term playbook for Dell Technologi...
Kroger's latest quarterly results sparked a sharp intraday move. Here’s a clear breakdown of the numbers, the drivers...
A wave of new analyst ratings hits screens Friday, touching auto parts, semiconductors, software and biotech. Upgrade...
Oil traders confront a rare overbought signal as crude-oil futures haven’t been this overstretched in decades. Market...
SpaceX faces a towering IPO target: a $1.5 trillion market cap. Analysts say the math hinges on unprecedented growth ...
MP Materials is turning a quiet corner in the US defense supply chain, with Pentagon-backed pricing and a plan to bui...